Posted on Feb 7 2023 6:55 AM

"Acne is a skin condition that arises when the hair follicles get plugged with dead skin cells and oil. This condition is most common among teenagers, although it affects people of all ages. The most common medication are antibiotics, retinoid, and retinoid-like drugs. The increasing prevalence of skin disorders is one of the major factors augmenting the demand for the product globally during the forecast period."

In 2021, the market for acne treatments was estimated to be worth USD 8.99 billion. The market is anticipated to expand at a CAGR of 4.8% from 2022 to 2029, rising from USD 9.36 billion in 2022 to USD 12.97 billion. The COVID-19 pandemic has had an unprecedented and staggering impact on the world, and demand for acne treatment has been lower than expected in all regions compared to pre-pandemic levels. According to our research, the global market showed a drop of -5.8% in 2020 compared to 2019.

Industry Development

• January 2021: GlaxoSmithKline plc announced that it entered into an agreement with Eligo BioScience with an aim to advance Eligobiotics for treating and preventing acne vulgaris with an approach of CRISPR-based therapy for strain-specific microbiome modulation.

Ask for In-depth Report Sample: https://www.fortunebusinessinsights.com/enquiry/sample/acne-treatment-market-103361

Declining Patient Visits & Losses in Revenue by Dominant Players to Limit Growth During Pandemic

The ongoing pandemic shifted the market of acne treatment toward a downward spiral regarding market growth due to various factors, including declining patient visits to hospitals and decreased patients seeking treatments globally. The prominent players reported declined revenue due to limited production and a shattered workforce due to irregular lockdowns and restrictions of movement on the general population. Limited access to dermatologists during the ongoing pandemic further decreases the market growth during the forecast period. However, during the fourth quarter of 2021, the market is expected to revive due to increasing patient pool and rising demand for drugs.

Segments

• Based on product, the market is divided into retinoids, antibiotics, isotretinoin, and others.
• By route of administration, the market is segmented into topical and oral.
• With respect to age group, the market is fragmented into 10 to 17, 18 to 44, 45 to 64, and 65 above.
• By distribution channel, the market is bifurcated into retail & online pharmacies and hospital pharmacies.
• In terms of geography, the market is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Report Coverage

The report provides a comprehensive view by presenting critical aspects such as market size & forecast, prominent regions, ongoing product launches, and an overview of technological developments. Additionally, the report also focuses on leading companies, leading products from all segments and subsegments, and ongoing industry developments. Also, factors that are expected to impact the market in a considerable way are also mentioned in the report.

To Get This Report Customized, Visit: https://www.fortunebusinessinsights.com/enquiry/customization/acne-treatment-market-103361

Rising Prevalence of Acne Worldwide and Launching Novel Product Will Boost Market Growth

Factors such as the increasing prevalence of skin conditions and the rising number of patients opting for treatments and solutions in developed and developing economies will boost the acne treatment market growth during the forecast period. Additionally, the introduction of a wide range of treatment products, including retinoids, isotretinoids, and antibiotics in the oral and topical form will increase the footprint of the market. Also, launching novel drugs by prominent players and rising number of clinical trials will fuel the growth of the market.

However, rising side effects pertaining to the current range of market products will limit the growth of the market during the forecast period.

North America to Reign Dominance During Forecast Period due to Increasing Consumer Concerns

North America will occupy the largest acne treatment market share during the forecast period due to the rising prevalence of acne in the region coupled with rising consumer concerns related to beauty. Additionally, the launch of new products by prominent players in the region and a significant rise in the patient population will increase the footprint of the market.

Europe will witness significant market share in terms of global contribution due to the increasing patient pool in the region coupled with rising investment for R&D used for treating dermatology conditions. The rising adoption of advanced treatments and solutions will further push the market share toward a higher volume.

Asia Pacific will hold the fastest growing CAGR due to rising awareness regarding the population about several drugs combined with the rising number of companies entering the region.

Inorganic Growth Attributes & Product Development to Help Prominent Players Establish Dominance

The sector of acne treatment is characterized by the presence of many larger and small players operating globally. The prominent players have established their position in the market by encompassing a diversified market portfolio, triggering a higher growth in revenue. For example, in November 2021, Sun Pharmaceutical Industries Ltd. announced the launching WINLEVI (clascoterone) cream 1% in the U.S. for treating topical treatment of acne vulgaris in patients ranging from 12 years and older. The dominant players in the market are Allergan, Galderma S.A., and Bausch Health Companies. The competitive landscape in the market is focused on players having a small domestic offering within their portfolio.

Get Quote:  https://www.fortunebusinessinsights.com/enquiry/get-a-quote/acne-treatment-market-103361

List of Key Players Present in the Market

• Allergan (Ireland)
• Botanix Pharmaceuticals (Australia)
• GALDERMA (Switzerland)
• Bausch Health Companies Inc (U.S.) 
• GlaxoSmithKline Plc (U.K.)
• Bayer AG (Germany)
• Valeant Pharmaceutical International, Inc (U.S.)
• Johnson & Johnson (U.S.)
• Pfizer Inc. (U.S.)
• Teva Pharmaceutical Industries Ltd. (Israel)

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. 
Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: [email protected]